DrugApproval

FDA Drug Approval Process Under Scrutiny: Insights from Biogen and Sarepta's Rapid Approvals

15 hours ago

The recent approvals of drugs from Biogen and Sarepta have sparked significant debate regarding the Federal Drug Administration's (FDA) regulatory processes, raising questions about the thoroughness and consistency of drug reviews. A detailed report indicates that these swift approvals may highlight gaps within the FDA's existing frameworks.

Lilly Aims for Breakthrough: New Weight Loss Pill Approval Expected in Early 2026

2 days ago

Lilly, the pharmaceutical giant known for its innovative drug development, is setting its sights on a promising new weight loss medication, with expectations for approval arriving in early 2026. The announcement was made by the company's CEO during a recent press conference, where he underscored the potential impact this new treatment could have on the obesity epidemic currently affecting millions worldwide.

EU Reverses Course, Approves Eisai's Alzheimer's Drug After Earlier Rejection

2 months ago

In a significant shift in regulatory stance, the European Union has granted approval to Eisai Co.'s Alzheimer's treatment, marking a notable turnaround from its earlier decision to reject the drug. This development stands to impact the treatment landscape for Alzheimer’s disease and offers renewed hope for patients suffering from this debilitating condition.